2,2′-Pyridoin derivatives protect HL-60 cells against oxidative stress

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 19, 2008, Pages 5290-5293

  Hatanaka, Masashi ^a   Nishizawa, Chiho ^a   Kakinoki, Tomohiro ^a   Takahashi, Kyoko ^a   Nakamura, Shigeo ^a   Mashino, Tadahiko ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Antioxidant; Cytoprotective effect; Pyridoin; Radical scavenger

Indexed keywords

2,2' PYRIDOIN DERIVATIVE; ASCORBIC ACID; HYDROGEN PEROXIDE; KETONE DERIVATIVE; PYRIDINE DERIVATIVE; SOLVENT; UNCLASSIFIED DRUG; 2,2' PYRIDOIN; 2,2'-PYRIDOIN; ANTIOXIDANT; SCAVENGER;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL DEATH; CELL PROTECTION; CELL STRAIN HL 60; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SCREENING; HUMAN; HUMAN CELL; LIPID PEROXIDATION; OXIDATION; OXIDATIVE STRESS; CHEMICAL STRUCTURE; CHEMISTRY; SYNTHESIS;

ANTIOXIDANTS; ASCORBIC ACID; CELL DEATH; FREE RADICAL SCAVENGERS; HL-60 CELLS; HUMANS; HYDROGEN PEROXIDE; MOLECULAR STRUCTURE; OXIDATIVE STRESS; PYRIDINES;

EID: 52049107620     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.08.057     Document Type: Article

References (19)

1. Kappus H. Arch. Toxicol. 60 (1987) 144
2. Cochrane C.G. Am. J. Med. 91 (1991) 23S
3. Gutteridge J.M.C. Free Radic. Res. Commun. 19 (1993) 141
4. Mccord J.M.N. Engl. J. Med. 312 (1985) 159
5. Clark R.A., Leidal K.G., Pearson D.W., and Nauseef W.M. J. Biol. Med. 262 (1987) 4065
6. Jacob R.A., and Burri B.J. J. Clin. Nutr. 63 (1996) 985S
7. Kato K., Terao S., Shinamoto N., and Hirata M. J. Med. Chem. 31 (1988) 793
8. Andrews G.C., and Crauford T. In: Seib P.A., and Tolbert B.M. (Eds). Ascorbic Acid; Chemistry, Metabolism, and Uses (1982), American Chemical Society, Washington, DC 59-80
9. Hatanaka M., Takahashi K., Nakamura S., and Mashino T. Bioorg. Med. Chem. 13 (2005) 6763
10. Arato E., Kurthy M., Jancso G., Sinai L., Kasza G., Verzar Z., Benko L., Cserepes B., Kollar L., and Roth E. Magy Seb. 59 (2006) 50
11. 2 atmosphere. Only the cells treated with DMSO were used as a non-treated control. The concentration of DMSO was set at 1 v/v%. The incubation mixture was centrifuged at 1000 rpm for 5 min, and the pellet was suspended in 2 mL of PBS (-). The cells were stained with trypan blue, and the viable cells were counted by a Vi-CELL™ cell viability analyzer (Beckman Coulter Inc.). Cell viability was calculated by the following equation. Cell Viability (%) = (treated viable cells)/(non-treated control viable cells) × 100.
12. Ovesna Z., Kozics K., Bader Y., Saiko P., Handler N., Erker T., and Szekeres T. Oncol. Rep 16 (2006) 617
13. Takamatsu S., Galal A.M., Ross S.A., Ferreira D., El-Sohly M.A., Ibrahim A.R., and El-Feraly F.S. Phytother. Res. 17 (2003) 963
14. Tsnatili-Kakoulidou A., Varvaresou A., Siatra-Papastaikoudi T., and Raevsky O.A. Quant. Struct.-Act. Relat. 18 (1998) 482
15. Lebel C.P., Ischiropoulos H., and Bondy S.C. Chem. Res. Toxicol. 5 (1992) 227
16. 2 atmosphere. The cells treated with DCFH-DA and DMSO were used as a control. The incubation mixture was centrifuged at 1000 rpm for 5 min, the pellet was suspended in 1 mL of BD FACS flow™, and the cells were quantified using a BD FACSCalibur™ flow cytometer (BD, Japan) with excitation and emission settings of 488 and 530 nm, respectively. The obtained data were analyzed by BD CellQuest™ Pro.
17. Inoue H., Matsumoto M., Kiyoi S., and Yamanaka M. Bull. Chem. Soc. Jpn. 46 (1973) 3900
18. Heirtzler F.R. Synlett 8 (1999) 1203
19. +), 244, 215, 201, 186, 173, 146, 136, 108, 93.